Quantbot Technologies’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $248K | Sell |
555
-154
| -22% | -$71.8K | 0.01% | 1109 |
|
|
2025
Q4 | $321K | Sell |
709
-3,018
| -81% | -$1.3M | 0.01% | 1084 |
|
|
2025
Q3 | $1.46M | Buy |
+3,727
| New | +$1.56M | 0.04% | 649 |
|
|
2024
Q1 | – | Sell |
-43
| Closed | -$17.5K | – | 1990 |
|
|
2023
Q4 | $17.5K | Sell |
43
-803
| -95% | -$297K | ﹤0.01% | 1435 |
|
|
2023
Q3 | $294K | Buy |
846
+273
| +48% | +$95.5K | 0.02% | 796 |
|
|
2023
Q2 | $202K | Buy |
+573
| New | +$193K | 0.01% | 969 |
|
|
2023
Q1 | – | Sell |
-7,826
| Closed | -$2.26M | – | 2115 |
|
|
2022
Q4 | $2.26M | Buy |
+7,826
| New | +$2.39M | 0.16% | 188 |
|
|
2022
Q3 | – | Sell |
-538
| Closed | -$151K | – | 2139 |
|
|
2022
Q2 | $151K | Buy |
538
+137
| +34% | +$36.7K | 0.01% | 1022 |
|
|
2022
Q1 | $104K | Buy |
+401
| New | +$95.2K | 0.01% | 1041 |
|
|
2021
Q4 | – | Sell |
-20,190
| Closed | -$3.66M | – | 1956 |
|
|
2021
Q3 | $3.66M | Buy |
+20,190
| New | +$3.94M | 0.27% | 88 |
|
|
2021
Q2 | – | Sell |
-5,118
| Closed | -$1.1M | – | 1900 |
|
|
2021
Q1 | $1.1M | Buy |
5,118
+5,034
| +5,993% | +$1.11M | 0.1% | 276 |
|
|
2020
Q4 | $19K | Sell |
84
-5,739
| -99% | -$1.32M | ﹤0.01% | 1022 |
|
|
2020
Q3 | $1.58M | Buy |
5,823
+3,442
| +145% | +$950K | 0.18% | 159 |
|
|
2020
Q2 | $691K | Buy |
+2,381
| New | +$646K | 0.09% | 212 |
|
|
2020
Q1 | – | Sell |
-9,743
| Closed | -$2.13M | – | 1424 |
|
|
2019
Q4 | $2.13M | Buy |
9,743
+2,864
| +42% | +$580K | 0.21% | 136 |
|
|
2019
Q3 | $1.17M | Sell |
6,879
-8,049
| -54% | -$1.42M | 0.11% | 217 |
|
|
2019
Q2 | $2.74M | Buy |
14,928
+6,227
| +72% | +$1.09M | 0.27% | 104 |
|
|
2019
Q1 | $1.6M | Sell |
8,701
-1,938
| -18% | -$358K | 0.15% | 188 |
|
|
2018
Q4 | $1.76M | Buy |
+10,639
| New | +$1.84M | 0.17% | 179 |
|
|
2018
Q3 | – | Sell |
-24,762
| Closed | -$4.21M | – | 1573 |
|
|
2018
Q2 | $4.21M | Buy |
24,762
+2,444
| +11% | +$379K | 0.29% | 80 |
|
|
2018
Q1 | $3.64M | Buy |
+22,318
| New | +$3.65M | 0.31% | 80 |
|
|
2017
Q4 | – | Sell |
-1,506
| Closed | -$228K | – | 1507 |
|
|
2017
Q3 | $228K | Sell |
1,506
-5,335
| -78% | -$803K | 0.02% | 671 |
|
|
2017
Q2 | $881K | Buy |
6,841
+946
| +16% | +$114K | 0.08% | 304 |
|
|
2017
Q1 | $644K | Buy |
5,895
+3,693
| +168% | +$325K | 0.07% | 341 |
|
|
2016
Q4 | $162K | Sell |
2,202
-3,619
| -62% | -$294K | 0.02% | 597 |
|
|
2016
Q3 | $507K | Buy |
+5,821
| New | +$550K | 0.06% | 358 |
|
|
2016
Q2 | – | Sell |
-4,445
| Closed | -$353K | – | 1379 |
|
|
2016
Q1 | $353K | Buy |
4,445
+228
| +5% | +$20.6K | 0.06% | 378 |
|
|
2015
Q4 | $530K | Sell |
4,217
-4,526
| -52% | -$546K | 0.09% | 244 |
|
|
2015
Q3 | $910K | Sell |
8,743
-252
| -3% | -$32.4K | 0.16% | 151 |
|
|
2015
Q2 | $1.11M | Buy |
8,995
+3,048
| +51% | +$384K | 0.2% | 120 |
|
|
2015
Q1 | $701K | Buy |
+5,947
| New | +$713K | 0.17% | 161 |
|
Other funds holding VRTX
VCM
VPM
Quantbot Technologies's VRTX Position: Q1 2026 in Review
Quantbot Technologies reduced its Vertex Pharmaceuticals (VRTX) stake by 22% in Q1 2026, selling an estimated $71.8K and leaving 555 shares worth $248K. The position accounts for 0.01% of the portfolio, ranked #1109.
Quantbot Technologies first reported a position in VRTX in Q1 2015 and has held it in 31 quarters since. The position peaked at $4.21M in Q2 2018. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Quantbot Technologies held 555 shares of Vertex Pharmaceuticals worth $248K as of Q1 2026.
- Quantbot Technologies sold 154 Vertex Pharmaceuticals shares in Q1 2026, an estimated $71.8K.
- Vertex Pharmaceuticals made up 0.01% of Quantbot Technologies's portfolio in Q1 2026, its #1109 holding.
- Quantbot Technologies first reported a position in Vertex Pharmaceuticals in Q1 2015 and has held it in 31 quarters since.
- Quantbot Technologies's Vertex Pharmaceuticals position peaked at $4.21M in Q2 2018.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.